TY - JOUR
T1 - Cardiovascular Complications of Down Syndrome
T2 - Scoping Review and Expert Consensus
AU - Dimopoulos, Konstantinos
AU - Constantine, Andrew
AU - Clift, Paul
AU - Condliffe, Robin
AU - Moledina, Shahin
AU - Jansen, Katrijn
AU - Inuzuka, Ryo
AU - Veldtman, Gruschen R.
AU - Cua, Clifford L.
AU - Tay, Edgar Lik Wui
AU - Opotowsky, Alexander R.
AU - Giannakoulas, George
AU - Alonso-Gonzalez, Rafael
AU - Cordina, Rachael
AU - Capone, George
AU - Namuyonga, Judith
AU - Scott, Charmaine H.
AU - D'Alto, Michele
AU - Gamero, Francisco J.
AU - Chicoine, Brian
AU - Gu, Hong
AU - Limsuwan, Alisa
AU - Majekodunmi, Tosin
AU - Budts, Werner
AU - Coghlan, Gerry
AU - Broberg, Craig S.
N1 - Publisher Copyright:
© 2023 Lippincott Williams and Wilkins. All rights reserved.
PY - 2023/1/31
Y1 - 2023/1/31
N2 - Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down syndrome. Congenital heart disease is the most common cardiovascular condition in this group, present in up to 50% of people with Down syndrome and contributing to poor outcomes. Additional factors contributing to cardiovascular outcomes include pulmonary hypertension; coexistent pulmonary, endocrine, and metabolic diseases; and risk factors for atherosclerotic disease. Moreover, disparities in the cardiovascular care of people with Down syndrome compared with the general population, which vary across different geographies and health care systems, further contribute to cardiovascular mortality; this issue is often overlooked by the wider medical community. This review focuses on the diagnosis, prevalence, and management of cardiovascular disease encountered in people with Down syndrome and summarizes available evidence in 10 key areas relating to Down syndrome and cardiac disease, from prenatal diagnosis to disparities in care in areas of differing resource availability. All specialists and nonspecialist clinicians providing care for people with Down syndrome should be aware of best clinical practice in all aspects of care of this distinct population.
AB - Cardiovascular disease is a leading cause of morbidity and mortality in individuals with Down syndrome. Congenital heart disease is the most common cardiovascular condition in this group, present in up to 50% of people with Down syndrome and contributing to poor outcomes. Additional factors contributing to cardiovascular outcomes include pulmonary hypertension; coexistent pulmonary, endocrine, and metabolic diseases; and risk factors for atherosclerotic disease. Moreover, disparities in the cardiovascular care of people with Down syndrome compared with the general population, which vary across different geographies and health care systems, further contribute to cardiovascular mortality; this issue is often overlooked by the wider medical community. This review focuses on the diagnosis, prevalence, and management of cardiovascular disease encountered in people with Down syndrome and summarizes available evidence in 10 key areas relating to Down syndrome and cardiac disease, from prenatal diagnosis to disparities in care in areas of differing resource availability. All specialists and nonspecialist clinicians providing care for people with Down syndrome should be aware of best clinical practice in all aspects of care of this distinct population.
KW - Down syndrome
KW - cardiovascular diseases
KW - heart defects, congenital
KW - hypertension, pulmonary
UR - http://www.scopus.com/inward/record.url?scp=85147150771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85147150771&partnerID=8YFLogxK
U2 - 10.1161/CIRCULATIONAHA.122.059706
DO - 10.1161/CIRCULATIONAHA.122.059706
M3 - Review article
C2 - 36716257
AN - SCOPUS:85147150771
SN - 0009-7322
VL - 147
SP - 425
EP - 441
JO - Circulation
JF - Circulation
IS - 5
ER -